Nitorum Capital L.P. Decreases Position in ICU Medical, Inc. (NASDAQ:ICUI)

Nitorum Capital L.P. lowered its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 7.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 200,045 shares of the medical instruments supplier's stock after selling 16,408 shares during the period. ICU Medical accounts for approximately 3.6% of Nitorum Capital L.P.'s portfolio, making the stock its 12th largest position. Nitorum Capital L.P. owned 0.82% of ICU Medical worth $31,041,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of ICUI. Barclays PLC grew its stake in shares of ICU Medical by 15.6% during the third quarter. Barclays PLC now owns 59,207 shares of the medical instruments supplier's stock worth $10,790,000 after purchasing an additional 8,010 shares in the last quarter. Franklin Resources Inc. increased its position in shares of ICU Medical by 99.3% during the third quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier's stock worth $2,111,000 after purchasing an additional 5,834 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock valued at $23,130,000 after purchasing an additional 25,031 shares during the last quarter. Diversified Trust Co boosted its position in shares of ICU Medical by 32.3% in the 4th quarter. Diversified Trust Co now owns 3,301 shares of the medical instruments supplier's stock valued at $512,000 after purchasing an additional 805 shares during the period. Finally, Inspire Investing LLC grew its stake in ICU Medical by 13.2% during the 4th quarter. Inspire Investing LLC now owns 2,601 shares of the medical instruments supplier's stock worth $404,000 after buying an additional 303 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Price Performance

Shares of ICU Medical stock traded up $0.10 during trading on Thursday, reaching $136.69. The company's stock had a trading volume of 180,236 shares, compared to its average volume of 274,141. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a 12-month low of $96.97 and a 12-month high of $196.26. The company has a market capitalization of $3.36 billion, a P/E ratio of -29.91 and a beta of 0.86. The business has a 50 day moving average price of $142.32 and a 200-day moving average price of $157.35.

Wall Street Analyst Weigh In

Several research firms have commented on ICUI. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. KeyCorp cut their price target on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Raymond James set a $97.00 price target on ICU Medical in a research report on Wednesday, March 12th. Finally, StockNews.com lowered ICU Medical from a "buy" rating to a "hold" rating in a report on Thursday, April 24th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, ICU Medical currently has a consensus rating of "Moderate Buy" and an average target price of $162.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.